Nunzia Pharmaceutical Company (NUNZ)
OTCMKTS · Delayed Price · Currency is USD
0.0001
+0.0001 (9,900.00%)
At close: Aug 11, 2025

Nunzia Pharmaceutical Company Company Description

Nunzia Pharmaceutical Company operates as a pharmaceutical and nutraceutical company.

The company owns the right to manufacture, market, and distribute Nunzia, a nutraceutical that treats autism, fragile X, ADHD, PTSD, and other disorders.

It offers its products through wholesalers, as well as through its website nunziapharma.com. The company was formerly known as Arizona Gold and Onyx Mining Company and changed its name to Nunzia Pharmaceutical Company in February 2018.

Nunzia Pharmaceutical Company was incorporated in 1986 and is based in Long Beach, California.

Nunzia Pharmaceutical Company
CountryUnited States
Founded1986
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
Employees4
CEOSara Gonzales

Contact Details

Address:
1627 West 14th Street
Long Beach, Utah 90813
United States
Phone714 609 9117
Websitenunziapharma.com

Stock Details

Ticker SymbolNUNZ
ExchangeOTCMKTS
Stock TypeCommon Stock
Share ClassClass A Shares
Fiscal YearJanuary - December
Reporting CurrencyUSD
ISIN NumberUS67097W1027
SIC Code2833

Key Executives

NamePosition
Sara P. GonzalesChief Executive Officer and Director
Michael MitsunagaPresident, Chief Financial Officer, Treasurer, Secretary and Director
Dr. Shujie CuiChief Medical Officer, Chief Science Officer and Director